1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow nirsevimab: new trials by email Literature Review of nirsevimab trials Research Report on nirsevimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children Nirsevimab - RSV Infection | Phase 2 | Completed | AstraZeneca | 100 | 2020-08-19 | 2023-11-15 |
Respiratory Syncytial Virus Infections (1)
AstraZeneca (1)
Belgium (1) · Japan (1) · Poland (1) · South Africa (1) · Spain (1) · Ukraine (1) · United Kingdom (1) · United States (1)